EnVVeno Historical Income Statement
| NVNO Stock | USD 2.83 0.10 3.41% |
Historical analysis of EnVVeno Medical income statement accounts such as Total Operating Expenses of 26.5 M can show how well enVVeno Medical Corp performed in making a profits. Evaluating EnVVeno Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of EnVVeno Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining enVVeno Medical Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether enVVeno Medical Corp is a good buy for the upcoming year.
EnVVeno |
About EnVVeno Income Statement Analysis
enVVeno Medical Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to EnVVeno Medical shareholders. The income statement also shows EnVVeno investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
EnVVeno Medical Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of enVVeno Medical Corp. It is also known as EnVVeno Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from EnVVeno Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into enVVeno Medical Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, EnVVeno Medical's Depreciation And Amortization is very stable compared to the past year. As of the 13th of December 2024, Total Operating Expenses is likely to grow to about 26.5 M, while Interest Expense is likely to drop about 224.9 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 18.7K | 263K | 236.7K | 224.9K | Depreciation And Amortization | 452.9K | 525K | 220K | 387.0K |
EnVVeno Medical income statement Correlations
Click cells to compare fundamentals
EnVVeno Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EnVVeno Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 1.0M | 384.0K | 452.9K | 525K | 220K | 387.0K | |
| Interest Expense | 49.9K | 3.7K | 18.7K | 263K | 236.7K | 224.9K | |
| Other Operating Expenses | 7.1M | 9.1M | 16.9M | 24.9M | 25.2M | 12.7M | |
| Operating Income | (7.7M) | (9.1M) | (16.9M) | (24.9M) | (25.2M) | (24.0M) | |
| Ebit | (7.7M) | (9.1M) | (17.2M) | (25.0M) | (25.2M) | (24.0M) | |
| Ebitda | (6.6M) | (8.8M) | (16.8M) | (24.5M) | (25.0M) | (23.8M) | |
| Total Operating Expenses | 7.1M | 9.1M | 16.9M | 24.9M | 25.2M | 26.5M | |
| Income Before Tax | (7.6M) | (9.1M) | (16.5M) | (24.7M) | (23.5M) | (22.3M) | |
| Total Other Income Expense Net | 49.9K | (360.0) | 364.7K | 263K | 1.7M | 1.8M | |
| Net Income | (7.6M) | (8.9M) | (16.2M) | (24.3M) | (23.5M) | (22.3M) | |
| Income Tax Expense | 588.8K | (215.5K) | (331.4K) | (365K) | (419.8K) | (398.8K) | |
| Gross Profit | 31.2K | (384.0K) | (452.9K) | (525K) | (546K) | (518.7K) | |
| Net Interest Income | 49.9K | 3.7K | 18.7K | 161K | 172K | 180.6K | |
| Selling General Administrative | 4.9M | 4.9M | 11.2M | 15.0M | 12.0M | 9.4M | |
| Net Income From Continuing Ops | (7.6M) | (9.1M) | (16.5M) | (24.7M) | (24.0M) | (22.8M) | |
| Research Development | 2.2M | 4.3M | 5.7M | 9.9M | 13.6M | 14.3M | |
| Reconciled Depreciation | 396.7K | 384.0K | 452.9K | 525K | 542K | 404.4K | |
| Net Income Applicable To Common Shares | (7.6M) | (9.7M) | (16.5M) | (24.7M) | (22.2M) | (21.1M) |
Pair Trading with EnVVeno Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.Moving against EnVVeno Stock
| 0.6 | MD | Mednax Inc | PairCorr |
| 0.6 | ECOR | Electrocore LLC | PairCorr |
| 0.5 | DOCS | Doximity | PairCorr |
| 0.49 | VREX | Varex Imaging Corp | PairCorr |
| 0.48 | OM | Outset Medical | PairCorr |
The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.37) | Return On Equity (0.59) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.